Your browser doesn't support javascript.
loading
Performance of Two-Stage Cervical Cancer Screening With Primary High-Risk Human Papillomavirus Testing in Women Living With Human Immunodeficiency Virus.
Luckett, Rebecca; Mogowa, Neo; Li, Howard J; Erlinger, Adrienne; Hacker, Michele R; Esselen, Katharine; Feldman, Sarah; Shapiro, Roger; Morroni, Chelsea; Ramogola-Masire, Doreen.
Afiliação
  • Luckett R; Botswana Harvard AIDS Initiative Partnership, Gaborone, Botswana; the Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; the Department of Obstetrics and Gynaecology, University of Botswana, Gaborone, Botswana; Harvard Medical School, the Harvard T.H. Chan School of Public Health, and Brigham and Women's Hospital, Boston, Massachusetts; the Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, United Kingdo
Obstet Gynecol ; 134(4): 840-849, 2019 10.
Article em En | MEDLINE | ID: mdl-31503167
ABSTRACT

OBJECTIVE:

To evaluate the performance of cervical cancer screening algorithms for women living with human immunodeficiency virus (HIV), using primary high-risk human papillomavirus (HPV) testing followed by cytology, visual inspection with acetic acid, or colposcopy.

METHODS:

We conducted a prospective cohort study of women living with HIV in Botswana. All participants underwent high-risk HPV testing. Participants with positive high-risk HPV test results underwent cytology, visual inspection with acetic acid, colposcopy, and biopsy. Participants with negative high-risk HPV test results also underwent cytology. Histopathology was the reference standard for determination of preinvasive cervical disease and cervical cancer. Sensitivity, specificity, positive predictive value (PPV), negative predictive value, and likelihood ratios (LR) of high-risk HPV-based two-stage screening algorithms were calculated.

RESULTS:

Among 300 women screened, 88 (29%) had a positive high-risk HPV test result, and 29 of the 88 (35%) women who tested positive for high-risk HPV had CIN 2 or higher on histopathology. High-risk HPV followed by colposcopy resulted in a sensitivity of 83%, specificity of 49%, PPV of 47%, LR+ of +1.6, and LR- of -0.4. High-risk HPV followed by visual inspection with acetic acid resulted in a reduced sensitivity of 59%, specificity of 49%, PPV of 39%, LR+ of +1.2, and LR- of -0.8. High-risk HPV testing followed by cytology also resulted in a reduced sensitivity of 62%, specificity of 77%, PPV of 60%, LR+ of +2.7, and LR- of -0.5. Stratification by HPV 16/18/45 did not improve performance of the algorithms.

CONCLUSION:

In a high-risk population with HIV, high-risk HPV testing followed by colposcopy demonstrated the highest sensitivity and PPV in detecting high-grade cervical dysplasia. Allocating resources to colposcopy in resource-limited settings may be more effective than other screening strategies.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Neoplasias do Colo do Útero / Papillomavirus Humano 16 / Papillomavirus Humano 18 Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Neoplasias do Colo do Útero / Papillomavirus Humano 16 / Papillomavirus Humano 18 Idioma: En Ano de publicação: 2019 Tipo de documento: Article